How do you demonstrate that your combination product will meet its specifications in a premarket application? In this session, a panel of experts will share some challenges of developing a combination product control strategy in a pharmaceutical development framework, lifecycle management, and global trends. Highlights include specific recommendations from the FDA EDDO guidance, determining which EDDOs to place on release and/or stability testing, factors that determine effective design and/or manufacturing upstream control for EDDOs, and more.
